Parcion Private Wealth’s Novartis NVS Stock Holding History

Parcion Private Wealth’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,414	Closed	-$310K	–	192
2022 Q4	$310K	Sell	3,414 -48,148	-93%	-$4.06M	0.03%	162
2022 Q3	$3.92M	Buy	51,562 +930	+2%	+$77.1K	0.44%	56
2022 Q2	$4.35M	Sell	50,632 -701	-1%	-$61.5K	0.43%	58
2022 Q1	$4.51M	Sell	51,333 -5,729	-10%	-$496K	0.42%	57
2021 Q4	$5.17M	Buy	57,062 +3,635	+7%	+$302K	0.47%	52
2021 Q3	$4.45M	Buy	53,427 +221	+0.4%	+$19.9K	0.4%	62
2021 Q2	$4.86M	Sell	53,206 -157	-0.3%	-$14K	0.49%	58
2021 Q1	$4.56M	Buy	53,363 +7,857	+17%	+$705K	0.52%	56
2020 Q4	$4.3M	Buy	45,506 +3,235	+8%	+$283K	0.57%	47
2020 Q3	$3.7M	Buy	42,271 +10,264	+32%	+$889K	0.57%	40
2020 Q2	$2.83M	Sell	32,007 -307	-1%	-$26.5K	0.48%	39
2020 Q1	$2.66M	Buy	32,314 +613	+2%	+$54.7K	0.73%	25
2019 Q4	$3M	Buy	+31,701	New	+$2.84M	0.66%	33

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Parcion Private Wealth's NVS Position: Q1 2023 in Review

Parcion Private Wealth sold out of Novartis (NVS) in Q1 2023, closing a stake of 3,414 shares — an estimated $310K sold.

Parcion Private Wealth first reported a position in NVS in Q4 2019 and held it in 13 quarters. The position peaked at $5.17M in Q4 2021. 1,180 funds tracked by Wall St. Rank hold NVS as of Q1 2023.

Parcion Private Wealth reported no remaining Novartis position as of Q1 2023 after selling out during the quarter.
Parcion Private Wealth sold 3,414 Novartis shares in Q1 2023, an estimated $310K.
Parcion Private Wealth first reported a position in Novartis in Q4 2019 and held it in 13 quarters.
Parcion Private Wealth's Novartis position peaked at $5.17M in Q4 2021.
1,180 funds tracked by Wall St. Rank held Novartis as of Q1 2023.

Based on Parcion Private Wealth's 13F filing for Q1 2023, filed 11 May 2023.